NLP Research

Clinical Trial in Progress - Replication of earlier Australian trial on group treatment for depression

In 2000 an Australian clinical trial of our non-pharmaceutical approach to treatment of depression demonstrated that in excess of 80% of people suffering from moderate-to-severe depression could have their depression completely resolved within days.

You can read the complete paper by clicking on "Research" in the menu column to your left. This paper has been peer-reviewed and published in the academic journal "Frontier Perspectives".

A web site for depression patients has been created at www.realhelpfordepression.com.

New Trials in 2007-8

We have two groups of depression patients in Uruguay and Argentina ready to start replication of this earlier Australian clinical trial of our new treatment program for depression, utilising BMSA.

The principal investigator in Uruguay is Alvaro Berrutti, MD and in Argentina, Alexander Andersson, MD. Dr Berrutti is a psychiatrist and Dr Andersson a neurologist, both of them enjoying great prestige in their countries.

The project will utilise a "four-blinded" procedure:

Group A of professionals will do the diagnosis.
Group B will run the treatments.
Group C will check results.
Group D will do all statistical work.

There will not be any kind of information permeating the different groups. Rather each group will do its specific task (diagnosis, treatment, evaluation and stats) with zero input from other groups.

Finally, yet another group of independent professionals will do the peer review work of the study.

Whilst the study is not randomised, it will nevertheless provide more rigorous examination of BMSA (or earlier associated techniques) than has been undertaken previously. Excitingly, brain mapping will be utilised to further examine outcomes.

If you are a medical practitioner and would like to be kept up to date on trial progress, you may like to subscribe to our free monthly journal "Journal of Modern Practice" on www.bmsa-int.com.